|
|
|
| |
|
|
| |
The latest gastroenterology news from News Medical |
|
|
|
 | | | A breakthrough molecular discovery could neutralize gluten and protect coeliac patients A research project led by the Institute for Research in Nutrition and Food Safety (INSA) and the Faculty of Pharmacy and Food Sciences at the University of Barcelona, together with the Molecular Biology Institute of Barcelona (IBMB) of the CSIC (which stands for Consejo Superior de Investigaciones Científicas), has successfully designed and tested a gluten-degrading molecule that is a promising ally in the management of coeliac disease, an... | | | | | The role of hydration in gut function Hydration and nutrition work together in digestion, influencing fiber tolerance, gut function, and digestive symptoms. | |
|
|
| |  | | | Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, do not respond to commonly used therapies. | | | | | A study, led by experts at the University of Nottingham, has found that persistent and distressing upper gut symptoms experienced by people with hypermobile Ehlers-Danlos syndrome (hEDS), are not due to structural problems with the gullet (esophagus), as previously assumed. | | | | | Severe acute pancreatitis (SAP) remains one of the most formidable challenges in gastrointestinal emergency medicine. | | | | | Your body weight and genes influence the types of bacteria you have in your gut. In turn, this appears to affect the risk of developing conditions such as coeliac disease and haemorrhoids. | | | | | Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, do not respond to commonly used therapies. | | | | | The study found that Clostridium perfringens was occasionally detected in raw or not-ready-to-eat meat products, but rarely appeared at concerning levels in cooked ready-to-eat meats. Even products linked to cooling deviations did not exceed 2 log CFU/g, suggesting that illness-associated growth during commercial stabilization is highly unlikely. | |
|
|
|
|
|
|
|